ADVANZ PHARMA M&A Summary
ADVANZ PHARMA has acquired 6 companies of its own, including 1 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.
ADVANZ PHARMA’s largest acquisition to date was in 2015, when it acquired Amdipharm Mercury Co. - AMCo. for $3.5B. It’s largest disclosed sale occurred in 2015, when it sold Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection to Teligent for $10M. ADVANZ PHARMA has acquired in 3 different US states, and 4 countries. The Company’s most targeted sectors include life science (67%) and healthcare services (17%).
M&A Summary
-
M&A Total Activity7
- M&A Buy Activity6
- M&A Sell Activity1
- Total Sectors Invested 3
- Total Countries Invested 4
- M&A Buy/Sell Connections 4
Unlimited Searches
